Martin Heidecker
Chief Investment Officer
Cambridge, Massachusetts, United States
40 investmentsMartin Heidecker is a Chief Investment Officer based in Cambridge, Massachusetts, United States. Martin Heidecker has backed 40 companies, including Aignostics, T3 Pharmaceuticals and Dopavision. Investment focus areas include Health Care, Hospitals and Wellness.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (40)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Aignostics | — | — | — | — |
| 2 | T3 Pharmaceuticals | — | — | — | — |
| 3 | Dopavision | — | — | — | — |
| 4 | Topas Therapeutics | — | — | — | — |
| 5 | Actym | — | — | — | — |
| 6 | eTheRNA immunotherapies | — | — | — | — |
| 7 | STAT-Dx | — | — | — | — |
| 8 | Rinri Therapeutics | — | — | — | — |
| 9 | Rigontec | — | — | — | — |
| 10 | Hookipa Pharma | — | — | — | — |
| 11 | Tacalyx | — | — | — | — |
| 12 | NBE-Therapeutics | — | — | — | — |
Showing 1–12 of 40
Page 1 of 4
Access Full Contact Information
Get Martin Heidecker's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.